Johnson & Johnson

Johnson & Johnson as of Sept. 30, 2024

Portfolio Holdings for Johnson & Johnson

Johnson & Johnson holds 20 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Protagonist Therapeutics (PTGX) 25.8 $110M 2.4M 45.00
Rapport Therapeutics (RAPP) 12.0 $51M 2.5M 20.48
Legend Biotech Corporation Sponsored Ads (LEGN) 9.3 $40M 815k 48.73
Contineum Therapeutics Cl A (CTNM) 8.9 $38M 2.0M 19.14
CVRX (CVRX) 8.5 $36M 4.1M 8.81
Nanobiotix Sponsored Ads (NBTX) 7.6 $32M 5.6M 5.75
Procept Biorobotics Corp (PRCT) 6.7 $29M 358k 80.12
Meiragtx Holdings (MGTX) 6.5 $28M 6.6M 4.17
Neumora Therapeutics (NMRA) 5.7 $24M 1.8M 13.21
Xencor (XNCR) 3.5 $15M 748k 20.11
Fate Therapeutics (FATE) 2.8 $12M 3.4M 3.50
Arrowhead Pharmaceuticals (ARWR) 1.1 $4.8M 248k 19.37
Rallybio Corp (RLYB) 1.0 $4.3M 3.6M 1.17
Nano-X Imaging Ord Shs (NNOX) 0.2 $966k 159k 6.08
Vor Biopharma (VOR) 0.2 $752k 1.1M 0.70
D Fluidigm Corp Del (LAB) 0.1 $602k 312k 1.93
Adicet Bio (ACET) 0.1 $525k 365k 1.44
Chardan Healthcare Acqu- Ord (PHGE) 0.0 $196k 192k 1.02
Clearside Biomedical (CLSD) 0.0 $105k 83k 1.27
Senseonics Hldgs (SENS) 0.0 $19k 55k 0.35